Dr. Ramakrishna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Pediatric Hematology/Oncology - Lucile Packard Children's Hospital Stanford
1000 Welch Road, Suite 300
Palo Alto, CA 94304Phone+1 650-497-8953Fax+1 650-497-8959- Is this information wrong?
Summary
- Sneha Ramakrishna, M.D., is an Instructor of Pediatrics in the Division of Hematology and Oncology, working with Dr Crystal Mackall. Dr. Ramakrishna obtained her B. A. from the University of Chicago and her M.D. from the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. She completed her residency training in Pediatrics at the Children’s Hospital of Philadelphia and her fellowship in Pediatric Hematology/Oncology at the Johns Hopkins/National Cancer Institute combined program. Her research focuses on identifying mechanisms of relapse in patients following chimeric antigen receptor (CAR) T cell therapies and optimizing both CAR design and tumor sensitivity to improve long-term success of CAR T cell therapies.
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2015 - 2018
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2012 - 2015
- Case Western Reserve University School of MedicineClass of 2012
Certifications & Licensure
- CA State Medical License 2018 - 2024
- MD State Medical License 2015 - 2019
- PA State Medical License 2012 - 2015
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Phase I Dose Escalation Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies Start of enrollment: 2017 Oct 20
- CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies Start of enrollment: 2020 Jan 10
- GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas(DIPG) & Spinal Diffuse Midline Glioma(DMG) Start of enrollment: 2020 Jun 04
- Join now to see all
Publications & Presentations
PubMed
- CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.Rezvani, A. R., Liora M Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, Bita Sahaf, Hrishi Srinagesh, Parveen Shiraz, Neha Agarwal, Mark Hamilton, Courtney Erickson, ...> ;Leukemia. 2024 Mar 15
- 3 citationsImmune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi, Cristina F Contreras, Caroline Duault, Priyanka B Subrahmanyam, Warren Reynolds, Norma A Gutierrez, Reema Baskar, Cath...> ;Cancer Cell. 2024 Jan 8
- INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future Priorities.John A Ligon, Sneha Ramakrishna, Francesco Ceppi, Friso G J Calkoen, Caroline Diorio, Kara L Davis, Elad Jacoby, Stephen Gottschalk, Liora M Schultz, Christian M Capitini> ;Transplantation and Cellular Therapy. 2024 Feb 1
- Join now to see all
Abstracts/Posters
- Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) TransductionSneha Ramakrishna, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)Sneha Ramakrishna, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Team Science Award Recognizes 8 Pediatric Cancer Researchers at StanfordApril 28th, 2021
Grant Support
- Research Scholars GrantHyundai Hope On Wheels2020–2022
Hospital Affiliations
- Lucile Packard Children's Hospital StanfordPalo Alto, California
External Links
- Stanford Biohttps://profiles.stanford.edu/sneha-ramakrishna
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: